(Press Release) Virbac licenses MabGenesis’ therapeutic antibodies for canine diseases

Virbac, a global leader in animal health, announces it has licensed novel therapeutic antibodies from MabGenesis, a private biopharmaceutical company headquartered in Yokohama, Japan. Please see the joint press release here.